LegoChem Biosciences (Korea) Today
| 141080 Stock | KRW 95,500 3,900 3.92% |
Performance1 of 100
| Odds Of DistressLess than 10
|
LegoChem Biosciences is trading at 95500.00 as of the 30th of November 2024, a 3.92 percent decrease since the beginning of the trading day. The stock's open price was 99400.0. LegoChem Biosciences has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for LegoChem Biosciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of October 2024 and ending today, the 30th of November 2024. Click here to learn more.
LegoChem Biosciences, Inc. a biopharmaceutical company, focuses on the development of novel therapeutics utilizing its proprietary LegoChemistry medicinal drug discovery technology and ADC platform. LegoChem Biosciences, Inc. was founded in 2006 and is headquartered in Daejeon, South Korea. The company has 10.6 M outstanding shares. More on LegoChem Biosciences
Moving together with LegoChem Stock
Moving against LegoChem Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
LegoChem Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. LegoChem Biosciences' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding LegoChem Biosciences or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Life Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
LegoChem Biosciences (141080) is traded on KOSDAQ in Korea and employs 12 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 403.31 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate LegoChem Biosciences's market, we take the total number of its shares issued and multiply it by LegoChem Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. LegoChem Biosciences operates under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 10.6 M outstanding shares.
LegoChem Biosciences has accumulated about 29.39 B in cash with (42.05 B) of positive cash flow from operations.
Check LegoChem Biosciences Probability Of Bankruptcy
Ownership AllocationThe market capitalization of LegoChem Biosciences is W403.31 Billion. LegoChem Biosciences secures 19.53 % of its outstanding shares held by insiders and 8.26 % owned by institutional investors. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check LegoChem Ownership Details
LegoChem Biosciences Risk Profiles
Although LegoChem Biosciences' alpha and beta are two of the key measurements used to evaluate LegoChem Biosciences' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.45 | |||
| Semi Deviation | 3.72 | |||
| Standard Deviation | 4.38 | |||
| Variance | 19.16 |
LegoChem Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in LegoChem Biosciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
LegoChem Biosciences Corporate Management
Elected by the shareholders, the LegoChem Biosciences' board of directors comprises two types of representatives: LegoChem Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of LegoChem. The board's role is to monitor LegoChem Biosciences' management team and ensure that shareholders' interests are well served. LegoChem Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, LegoChem Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Young Cho | Head Researcher | Profile | |
| YongZu Kim | Chief Pres | Profile | |
| Sejin Park | Chief VP | Profile | |
| Yeong Oh | Chief VP | Profile | |
| Dae Lee | Head Researcher | Profile | |
| Ho Song | Head Researcher | Profile | |
| Hyang Lee | Head Researcher | Profile |
Other Information on Investing in LegoChem Stock
LegoChem Biosciences financial ratios help investors to determine whether LegoChem Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in LegoChem with respect to the benefits of owning LegoChem Biosciences security.